WEEKLY UPDATE
Aug 14
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  MDRD GFR
Slides/audio/handouts:    RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  :  ADC-2007(a)  :  RPA-2007(s/a)  :  RRI-2007(s/a/h)  : 
Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Murray  

Molitoris  

  Acute Kidney Injury. Congestive Heart Failure: A Nephrologist's Disease? (Murray) and AKI Therapeutics: From Bench to Commercialisation (Molitoris) Flash slide/audio
(ASN Clinical Nephrology Conference, November, 2007)
Murray: What's the role of the nephrologist in caring for patients with congestive heart failure? What should the optimal interaction be between nephrologists and cardiologists? What is cardiorenal syndrome? How does pharmacotherapy of congestive heart failure impact the kidney? What is the role of ultrafitration therapy?
Molitoris: What is the role of the academic medical center in commercializing new discoveries? In particular, what was the pathway for commercialization of a new method of supravital imaging of renal function through in vivo fluorescence microscopy that was developed at Indiana University?
(more...)


Qunibi  

Szczech  

  New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease Flash slide/audio
(ANNA National Symposium, April, 2008.)
Qunibi: How do the various phosphate binders compare in terms or their ability to control serum phosphorus in the real world? What are the population attributable risks to elevated serum phosphorus, calcium, and PTH? What is the evidence that calcium-based phosphate binder dose is linked to calcification, and to what extent might this be operating through hyperphosphatemia in noncompliant patients? What did the CARE-2 study show? What were the mortality outcomes results in RIND and DCOR? What do the 2003 KDOQI bone disease guidelines recommend regarding phosphate binders and what might be the economic implication of these recommendations? Szczech: What are the statistical issues involved when examining observational association of laboratory values (e.g. serum calcium, phosphorus, and PTH) vs. mortality? What characterizes patients with high serum phosphate? High serum calcium? What do time varying analyses of change in these values show? Are there any clinically relevant differences between calcium carbonate and calcium acetate? Which calcium-based binder types were used in the various trials -- RIND, Treat to Goal, DCOR, and CARE-2? What are the potential pitfalls of looking at intermediate outcomes in trials of phosphate binders?
(more...)


Hypertension, Cardiovascular
Fruit juice bad
Oily fish good for macular degeneration
Angiotensin polymorphism interacts with sodium intake
Drugs that raise HDL
Fenofibrate plus coenzyme Q10
Translating A1C assay into TAC glucose
Paricalcitol lowers albuminuria in RCT
Ethnicity and response to furosemide
Does fructose enhance gut Na absorption?
CKD, ESRD
Noninvasive coronary artery imaging (AHA statement)
K citrate no good for the bones
Vitamin K and the bones
Bicarb kinetics and energy expenditure in kids
Anemia and heart failure in the community
New prostate cancer screening guidelines
Total blood calcium pitfalls
Aldosterone and kidney fibrosis
Oral calcitriol and survival in early CKD
CKD in type 2 DM with NALD
FGF-23 ups mortality risk
Surgeon selection a big factor in fistula survival
Sympathetic overactivity in ESRD
Clinical Nephrology
Hyperkalemia due to penicillin
Estimated GFR may overestimate CKD
SLE-related soft tissue calcification




ASN Renal Week 2007
now in MP3
AUDIOFILE LIST (Renal Week 2007)

(22 talks)
Pleitropic Actions of Vitamin D: Beyond Bone Disease
R Bouillon, CF Garland, D Bikle, GM London

One Renal Biopsy is a Picture, the Second Biopsy is More a Movie: The Importance of Repeat Biopsy in the Management of Patients
S Hariharan, ISD Roberts, JC Jennette, F Ferrario

Novel Therapeutic and Diagnostic Strategies in the Treatment of Glomerular Disease
J Floege, DTM Chan, D Roccatello, HJ Anders

Novel Risk Factors for Cardivascular Disease in Chronic Kidney Disease
VS Balakrishnan and R Mehrotra

Information Technology in Dialysis
JA Sargent, M Suresh, JE Tattersall, B Savage




    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: August 21, 2008 (A21)
A21 NKF launches education toolkit targeting treatment of patients with HIV and CKD.
A21 DaVita establishes Florida hotline for dialysis patients to be used during hurricanes.
A21 Blocking androgen receptors in prostate cancer may paradoxically enhance tumor growth.
A21 Taste receptor for calcium present in the mouths of mice.
A21 AMAG receives fast track designation from FDA for ferumoxytol as an MRI contrast agent.
A20 79 million US adults have problems related to medical care induced debt.
A20 First red blood cells grown in the lab.
A20 Individual genome analysis shows that drug sensitivity may be poorly predicted by skin color (presumed race)
A20 New survey shows obesity rates continue to increase in the United States.
A19 Lowering homocysteine with folic acid and B vitamins fails to reduce CV events in heart disease patients.
A19 Low-level arsenic exposure linked to increased type 2 diabetes risk.
A19 Effect of grapefruit juice on drug absorption and metabolism: new complexities
A19 Chronic lead poisoning from contaminated urban soils.
A19 Obesity epidemic due to increased food intake, and not decreased activity level.
A19 FDA warns of hemorrhagic necrotizing pancreatitis with Byetta (exenatide)
A18 Researchers create milligram quantities of completely synthetic heparin
A18 Compensated organ donation pits the AMA against the NKF: The Satel article in Slate magazine.
A18 Novel type of gene silencing technology described.
A18 Wall Street Journal health blog debated ethics of organ donation, focusing on NKF opposition to the concept.
A18 Medicare finalizes its list of - no pay - preventable conditions in hospitalized patients.
General Advances Emphasis
archive
Sympathetic overactivity - the Cinderella of cardiovascular risk factors in dialysis patients
Vonend, Rump, and Ritz discuss the evidence for SNS overactivity in ESRD and what treatments may best mitigate this; from the July/August issue of Seminars in Dialysis. (more...)

The aggravating mechanisms of aldosterone on kidney fibrosis
Remuzzi and colleagues discuss how aldosterone may promote kidney fibrosis, and the potential benefits of halting this process; in the August 2008 issue of the J Am Soc Nephrol (JASN) (more...)

Pharmacogenetics of immunosuppressants: progress, pitfalls and promises
Cattaneo and colleagues review the data on polymorphisms of the thiopurine-S-methyltransferase and cytochrome P450 3A5 genotypes, but also discuss new research on the genetic variation of the targets of immunosuppresant drugs; in the July 2008 issue of the Am J Transplant. (more...)

Exercise and Dialysis
Johansen reviews the evidence of what the benefits are, what are the best types to recommend, and the new recs from the American College of Sports Medicine and the AHA for older individuals and for those with chronic diseases; from the July issue of Hemodialysis International. (more...)

Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
Abaterusso and colleagues discuss the realities and practical approaches of treating CKD in the elderly; from the July issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

When is it appropriate to order an ionized calcium?
Calvi and Bushinsky discuss how ionized calcium measurement may be better than albumin-corrected calcium in a number of intensive care situations, and also in some ambulatory settings; from the July issue of the J Am Soc Nephrol (JASN) (more...)

Lipid abnormalities and cardiovascular risk in renal disease
Ritz and Wanner review the effects of CKD on lipids, the evidence that lipid control may slow progression, and suggest treatment regimens in this population; from the June issue of the J Am Soc Nephrol (JASN) (more...)

Role of remission clinics in the longitudinal treatment of CKD
What is a remission clinic for CKD patients, and what are the results in terms of progression when patients are aggressively monitored and treated in this way? Ruggenenti and colleagues tells us, in the June issue of the J Am Soc Nephrol (JASN) (more...)

Staging of chronic kidney disease: time for a course correction
Bauer et al tell us why the NKF KDOQI staging system is seriously flawed; from the May issue of the J Am Soc Nephrol (JASN) (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
FREE
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...











 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99